Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vertex Pharmaceuticals Inc

NASDAQ: VRTX · Life Sciences · 5 alerts · CIK 875320

Share price
$537.79Close, Nov 16
Market cap
$136B
Shares outstanding
253.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vertex Pharmaceuticals Inc filings on SEC EDGAR ↗

4:10 PM ET 8-K
Leadership Change

Vertex Pharmaceuticals Leadership Change

Vertex Pharmaceuticals appointed Daniel Brennan to its Board of Directors, effective October 20, 2026, increasing the board size to eleven members. Mr. Brennan, the former CFO of Boston Scientific, will also serve on the Audit and Finance Committee and received an initial $400,000 restricted stock unit award.

Counterparty
Daniel Brennan

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.